233 related articles for article (PubMed ID: 11831890)
21. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
[TBL] [Abstract][Full Text] [Related]
22. Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor.
van Muijlwijk-Koezen JE; Timmerman H; van der Goot H; Menge WM; Frijtag Von Drabbe Künzel J; de Groote M; IJzerman AP
J Med Chem; 2000 Jun; 43(11):2227-38. PubMed ID: 10841801
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process.
Pastorin G; Federico S; Paoletta S; Corradino M; Cateni F; Cacciari B; Klotz KN; Gao ZG; Jacobson KA; Spalluto G; Moro S
Bioorg Med Chem; 2010 Apr; 18(7):2524-36. PubMed ID: 20304654
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
[TBL] [Abstract][Full Text] [Related]
25. Water-soluble pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as human A₃ adenosine receptor antagonists.
Baraldi PG; Saponaro G; Romagnoli R; Aghazadeh Tabrizi M; Baraldi S; Moorman AR; Cosconati S; Di Maro S; Marinelli L; Gessi S; Merighi S; Varani K; Borea PA; Preti D
J Med Chem; 2012 Jun; 55(11):5380-90. PubMed ID: 22568637
[TBL] [Abstract][Full Text] [Related]
26. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
27. [1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A
Federico S; Margiotta E; Salmaso V; Pastorin G; Kachler S; Klotz KN; Moro S; Spalluto G
Eur J Med Chem; 2018 Sep; 157():837-851. PubMed ID: 30144700
[TBL] [Abstract][Full Text] [Related]
28. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
[TBL] [Abstract][Full Text] [Related]
29. [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
Varani K; Merighi S; Gessi S; Klotz KN; Leung E; Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Borea PA
Mol Pharmacol; 2000 May; 57(5):968-75. PubMed ID: 10779381
[TBL] [Abstract][Full Text] [Related]
30. One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists.
Baraldi PG; Baraldi S; Saponaro G; Aghazadeh Tabrizi M; Romagnoli R; Ruggiero E; Vincenzi F; Borea PA; Varani K
J Med Chem; 2015 Jul; 58(13):5355-60. PubMed ID: 26046697
[TBL] [Abstract][Full Text] [Related]
31. Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation.
Taliani S; La Motta C; Mugnaini L; Simorini F; Salerno S; Marini AM; Da Settimo F; Cosconati S; Cosimelli B; Greco G; Limongelli V; Marinelli L; Novellino E; Ciampi O; Daniele S; Trincavelli ML; Martini C
J Med Chem; 2010 May; 53(10):3954-63. PubMed ID: 20408530
[TBL] [Abstract][Full Text] [Related]
32. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Preti D; Zaid AN; Saponaro G; Tabrizi MA; Baraldi S; Romagnoli R; Moorman AR; Varani K; Cosconati S; Di Maro S; Marinelli L; Novellino E; Borea PA
J Med Chem; 2011 Jul; 54(14):5205-20. PubMed ID: 21675777
[TBL] [Abstract][Full Text] [Related]
33. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
Li AH; Moro S; Melman N; Ji XD; Jacobson KA
J Med Chem; 1998 Aug; 41(17):3186-201. PubMed ID: 9703464
[TBL] [Abstract][Full Text] [Related]
35. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA
J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of novel pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives: potent and selective adenosine A3 receptor antagonists.
Banda V; Chandrasekaran B; Köse M; Vielmuth C; Müller CE; Chavva K; Gautham SK; Pillalamarri S; Mylavaram R; Akkinepally R; Pamulaparthy S; Banda N
Arch Pharm (Weinheim); 2013 Oct; 346(10):699-707. PubMed ID: 23996524
[TBL] [Abstract][Full Text] [Related]
37. Discovery of simplified N²-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: efficient synthetic approaches, biological evaluations and molecular docking studies.
Venkatesan G; Paira P; Cheong SL; Vamsikrishna K; Federico S; Klotz KN; Spalluto G; Pastorin G
Bioorg Med Chem; 2014 Mar; 22(5):1751-65. PubMed ID: 24518296
[TBL] [Abstract][Full Text] [Related]
38. [1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A
Federico S; Persico M; Trevisan L; Biasinutto C; Bolcato G; Salmaso V; Da Ros T; Gianferrara T; Prencipe F; Kachler S; Klotz KN; Pacor S; Moro S; Spalluto G
ChemMedChem; 2023 Nov; 18(21):e202300299. PubMed ID: 37675643
[TBL] [Abstract][Full Text] [Related]
39. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
40. 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.
Harada H; Asano O; Hoshino Y; Yoshikawa S; Matsukura M; Kabasawa Y; Niijima J; Kotake Y; Watanabe N; Kawata T; Inoue T; Horizoe T; Yasuda N; Minami H; Nagata K; Murakami M; Nagaoka J; Kobayashi S; Tanaka I; Abe S
J Med Chem; 2001 Jan; 44(2):170-9. PubMed ID: 11170626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
